Skip to main navigation Skip to search Skip to main content

Hidradenitis suppurativa and adalimumab in the COVID-19 era

  • Angelo Valerio Marzano
  • , Chiara Moltrasio
  • , Giovanni Genovese
  • , Giannicola Genovese
  • , Simona Muratori
  • , Paolo Dapavo
  • , Gabriella Fabbrocini
  • , Annalisa Patrizi
  • , Andrea Sechi
  • , Giuseppe Micali
  • , Michele Pellegrino
  • , Maria Gabriella Pellegrino
  • , Paolo Gisondi
  • , Valentina Dini
  • , Veronica Dini
  • , Luca Bianchi
  • , Luca Fania
  • , Annamaria Offidani
  • , Francesca Prignano
  • , Laura Atzori
  • Emanuele Miraglia, Serafinella Patrizia Cannavò, Vincenzo Bettoli, Luca Stingeni, Riccardo Balestri, Marina Venturini, Ketty Peris
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • University of Milan
  • University of Turin
  • University of Naples Federico II
  • University of Bologna
  • University of Catania
  • Ospedale della Misericordia, Grosseto
  • University of Verona
  • University of Pisa
  • University of Rome Tor Vergata
  • IRCCS Istituto Dermopatico dell'Immacolata - Roma
  • Marche Polytechnic University
  • University of Florence
  • University of Cagliari
  • University of Rome La Sapienza
  • University of Messina
  • University of Ferrara
  • University of Perugia
  • Ospedale S. Chiara
  • Spedali Civili Di Brescia

Research output: Contribution to journalArticle

Abstract

na
Original languageEnglish
Pages (from-to)748-749
Number of pages2
JournalDermatologic Therapy
Volume30
DOIs
Publication statusPublished - 2020

Keywords

  • adalimumab
  • hidradenitis suppurativa

Fingerprint

Dive into the research topics of 'Hidradenitis suppurativa and adalimumab in the COVID-19 era'. Together they form a unique fingerprint.

Cite this